Company Filing History:
4 out of 1,327 
2 out of 57 
Years Active: 2020-2023
Title: George Burslem: Innovator in Imide-Based Compounds
Introduction
George Burslem is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of biochemistry, particularly through his innovative work on imide-based compounds. With a total of four patents to his name, Burslem's inventions have the potential to impact various pharmacological applications.
Latest Patents
One of Burslem's latest patents is titled "Imide-based modulators of proteolysis and associated methods of use." This patent describes imide-based compounds, including bifunctional compounds, which serve as modulators of targeted ubiquitination. These compounds are particularly effective as inhibitors of various polypeptides and proteins that are degraded or inhibited by the bifunctional compounds. The invention details compounds that feature a ligand binding to the cereblon E3 ubiquitin ligase on one end and a moiety that binds a target protein on the other end. This design allows the target protein to be positioned near the ubiquitin ligase, facilitating its degradation and inhibition. The compounds can be synthesized to exhibit a wide range of pharmacological activities, making them versatile tools in the degradation and inhibition of targeted polypeptides.
Career Highlights
Throughout his career, George Burslem has worked with prestigious institutions, including Yale University and Arvinas Operations, Inc. His work has been instrumental in advancing the understanding of protein degradation mechanisms and their applications in drug development.
Collaborations
Burslem has collaborated with notable colleagues, including Craig M. Crews and Saul Jaime-Figueroa. These partnerships have contributed to the success of his research and the development of innovative solutions in the field.
Conclusion
George Burslem's contributions to the field of biochemistry through his patents on imide-based compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmacological applications.